CorMedix Inc. Files 8-K: Material Agreement & Equity Sales
Ticker: CRMD · Form: 8-K · Filed: Aug 12, 2025 · CIK: 1410098
| Field | Detail |
|---|---|
| Company | Cormedix Inc. (CRMD) |
| Form Type | 8-K |
| Filed Date | Aug 12, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001, $150,000,000, $1,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, filing
Related Tickers: CRMD
TL;DR
CRMD filed an 8-K on 8/12/25 for a material agreement and equity sales.
AI Summary
On August 12, 2025, CorMedix Inc. filed an 8-K report detailing a material definitive agreement. The filing also covers unregistered sales of equity securities and includes financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Berkeley Heights, NJ.
Why It Matters
This filing indicates significant corporate activity, including a new material agreement and potential equity transactions, which could impact the company's financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing involves a material definitive agreement and unregistered sales of equity, which can introduce financial and regulatory risks.
Key Numbers
- 001-34673 — SEC File Number (CorMedix Inc.'s SEC filing identifier.)
- 20-5894890 — IRS Employer Identification No. (CorMedix Inc.'s tax identification number.)
Key Players & Entities
- CorMedix Inc. (company) — Registrant
- August 12, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Berkeley Heights, NJ (location) — Principal Executive Offices
- 908-517-9500 (phone_number) — Registrant's Telephone Number
FAQ
What is the nature of the material definitive agreement filed by CorMedix Inc. on August 12, 2025?
The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in the summary information.
What type of equity securities were sold unregistered by CorMedix Inc.?
The filing mentions unregistered sales of equity securities, but the specific type and details of these securities are not detailed in the provided summary.
When was CorMedix Inc. incorporated and in which state?
CorMedix Inc. was incorporated in Delaware.
Where are CorMedix Inc.'s principal executive offices located?
CorMedix Inc.'s principal executive offices are located at 300 Connell Drive, Suite 4200, Berkeley Heights, NJ 07922.
What is the SEC file number for CorMedix Inc.?
The SEC file number for CorMedix Inc. is 001-34673.
Filing Stats: 791 words · 3 min read · ~3 pages · Grade level 10.4 · Accepted 2025-08-12 16:43:37
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share CRMD Nasdaq Glo
- $150,000,000 — ed its previously announced offering of $150,000,000 aggregate principal amount of its conve
- $1,000 — l to 74.2515 shares of Common Stock per $1,000 principal amount of Notes. The foregoin
Filing Documents
- ea0252859-8k_cormedix.htm (8-K) — 28KB
- ea025285901ex4-1_cormedix.htm (EX-4.1) — 787KB
- ex4-1_001.jpg (GRAPHIC) — 5KB
- ex4-1_002.jpg (GRAPHIC) — 4KB
- ex4-1_003.jpg (GRAPHIC) — 2KB
- ex4-1_004.jpg (GRAPHIC) — 2KB
- ex4-1_005.jpg (GRAPHIC) — 2KB
- ex4-1_006.jpg (GRAPHIC) — 1KB
- ex4-1_007.jpg (GRAPHIC) — 2KB
- 0001213900-25-075010.txt ( ) — 1164KB
- crmd-20250812.xsd (EX-101.SCH) — 3KB
- crmd-20250812_lab.xml (EX-101.LAB) — 33KB
- crmd-20250812_pre.xml (EX-101.PRE) — 22KB
- ea0252859-8k_cormedix_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. CorMedix Inc. Date: August 12, 2025 By: /s/ Joseph Todisco Joseph Todisco Chief Executive Officer